It's the most expensive "free" shot of all time.

Pfizer's Q2 earnings numbers parallel that of a top 5 global energy company. Of course, the slight difference here is that energy companies actually provide essential services for human flourishing, while Pfizer provides, well, government-backed snake oil.

This quarter, the drug company posted a total revenue of $27.7 billion, up 46.5% from $18.9 billion the same period of last year.

Net income is up 78% to $9.9 billion this quarter, from $5.5 billion in Q2 of 2021.